Prestige closes Breathe Right acquisition for $1B

• Prestige Consumer Healthcare closed its acquisition of the Breathe Right brand.
• The company completed the $1.045 billion transaction using cash and debt.
• The acquisition expands the company's product portfolio into a new category.

Prestige Consumer Healthcare (NYSE:PBH) closed its acquisition of the Breathe Right brand for $1.045 billion.

This closing completes an asset purchase agreement originally announced on March 20, 2026.

The net cost is approximately $900 million after deducting $150 million in anticipated tax benefits.

Prestige financed the brand transaction through available cash and a new Term Loan B.

Following the announcement, Prestige Consumer Healthcare's share price was down at $46.67.

Breathe Right was created in the 1990s within the nasal strip category.

The company stated that the brand will become its largest product line.